SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001070698-13-000073
Filing Date
2013-09-12
Accepted
2013-09-12 14:07:12
Documents
3
Period of Report
2013-09-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K DATED SEPTEMBER 12, 2013 rptp8k_091213_euprocysapprvl.htm 8-K 15138
2 RAPTOR PHARMACEUTICAL CORP PRESS RELEASE DATED SEPTEMBER 12, 2013 rptp_pr091213_euprocysapprvl.htm EX-99.1 19547
3 image00001.jpg GRAPHIC 5822
  Complete submission text file 0001070698-13-000073.txt   44224
Mailing Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949
Business Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949 415-382-1390
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-25571 | Film No.: 131093757
SIC: 2834 Pharmaceutical Preparations